182 related articles for article (PubMed ID: 19415461)
1. Enhancing of GM3 synthase expression during differentiation of human blood monocytes into macrophages as in vitro model of GM3 accumulation in atherosclerotic lesion.
Gracheva EV; Samovilova NN; Golovanova NK; Kashirina SV; Shevelev A; Rybalkin I; Gurskaya T; Vlasik TN; Andreeva ER; Prokazova NV
Mol Cell Biochem; 2009 Oct; 330(1-2):121-9. PubMed ID: 19415461
[TBL] [Abstract][Full Text] [Related]
2. Activation of ganglioside GM3 biosynthesis in human monocyte/macrophages during culturing in vitro.
Gracheva EV; Samovilova NN; Golovanova NK; Andreeva ER; Andrianova IV; Tararak EM; Prokazova NV
Biochemistry (Mosc); 2007 Jul; 72(7):772-7. PubMed ID: 17680770
[TBL] [Abstract][Full Text] [Related]
3. Activation of CMP-N-acetylneuraminic acid:lactosylceramide sialyltransferase during the differentiation of HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate.
Momoi T; Shinmoto M; Kasuya J; Senoo H; Suzuki Y
J Biol Chem; 1986 Dec; 261(34):16270-3. PubMed ID: 3465724
[TBL] [Abstract][Full Text] [Related]
4. [Activation of ganglioside GM3 biosynthesis in human blood mononuclear cells in atherosclerosis].
Gracheva EV; Samovilova NN; Piksina GF; Shishkina VS; Prokazova NV
Biomed Khim; 2013; 59(4):459-68. PubMed ID: 24502144
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of CMP-N-acetylneuraminic acid:lactosylceramide (alpha 2-3) sialyltransferase (GM3-synthase) from rat brain.
Preuss U; Gu X; Gu T; Yu RK
J Biol Chem; 1993 Dec; 268(35):26273-8. PubMed ID: 8253749
[TBL] [Abstract][Full Text] [Related]
6. Expression of GM3 synthase in human atherosclerotic lesions.
Bobryshev YV; Golovanova NK; Tran D; Samovilova NN; Gracheva EV; Efremov EE; Sobolev AY; Yurchenko YV; Lord RS; Cao W; Lu J; Saito M; Prokazova NV
Atherosclerosis; 2006 Jan; 184(1):63-71. PubMed ID: 15935355
[TBL] [Abstract][Full Text] [Related]
7. Total metabolic flow of glycosphingolipid biosynthesis is regulated by UDP-GlcNAc:lactosylceramide beta 1-->3N-acetylglucosaminyltransferase and CMP-NeuAc:lactosylceramide alpha 2-->3 sialyltransferase in human hematopoietic cell line HL-60 during differentiation.
Nakamura M; Tsunoda A; Sakoe K; Gu J; Nishikawa A; Taniguchi N; Saito M
J Biol Chem; 1992 Nov; 267(33):23507-14. PubMed ID: 1429695
[TBL] [Abstract][Full Text] [Related]
8. Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta. Hypothetical role of ganglioside GM3 in foam cell formation.
Bobryshev YV; Lord RS; Golovanova NK; Gracheva EV; Zvezdina ND; Prokazova NV
Biochim Biophys Acta; 2001 Feb; 1535(2):87-99. PubMed ID: 11341997
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells.
Chung TW; Choi HJ; Lee YC; Kim CH
Glycobiology; 2005 Mar; 15(3):233-44. PubMed ID: 15385432
[TBL] [Abstract][Full Text] [Related]
10. Purification to apparent homogeneity by immunoaffinity chromatography and partial characterization of the GM3 ganglioside-forming enzyme, CMP-sialic acid:lactosylceramide alpha 2,3-sialyltransferase (SAT-1), from rat liver Golgi.
Melkerson-Watson LJ; Sweeley CC
J Biol Chem; 1991 Mar; 266(7):4448-57. PubMed ID: 1999428
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial PCR approach to homology-based cloning: cloning and expression of mouse and human GM3-synthase.
Kapitonov D; Bieberich E; Yu RK
Glycoconj J; 1999 Jul; 16(7):337-50. PubMed ID: 10619706
[TBL] [Abstract][Full Text] [Related]
12. Expression cloning of mouse cDNA of CMP-NeuAc:Lactosylceramide alpha2,3-sialyltransferase, an enzyme that initiates the synthesis of gangliosides.
Fukumoto S; Miyazaki H; Goto G; Urano T; Furukawa K; Furukawa K
J Biol Chem; 1999 Apr; 274(14):9271-6. PubMed ID: 10092602
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.
Paccalet T; Coulombe Z; Tremblay JP
PLoS One; 2010 Apr; 5(4):e10055. PubMed ID: 20383336
[TBL] [Abstract][Full Text] [Related]
14. Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 synthase deficiency variants.
Dookwah M; Wagner SK; Ishihara M; Yu SH; Ulrichs H; Kulik MJ; Zeltner N; Dalton S; Strauss KA; Aoki K; Steet R; Tiemeyer M
Hum Mol Genet; 2023 Dec; 32(24):3323-3341. PubMed ID: 37676252
[TBL] [Abstract][Full Text] [Related]
15. Sialyltransferase Activity Assay for Ganglioside GM3 Synthase.
Inamori KI; Nitta T; Shishido F; Watanabe S; Ohno I; Inokuchi JI
Methods Mol Biol; 2023; 2613():101-110. PubMed ID: 36587074
[TBL] [Abstract][Full Text] [Related]
16. [A study of partial purification of ganglioside GD3 synthase and its enzymatic properties].
Kawano M
Hokkaido Igaku Zasshi; 1990 Jan; 65(1):26-40. PubMed ID: 2328944
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc:LacCer alpha 2-3 sialyltransferase (GM3 synthase).
Zebda N; Pedron S; Rebbaa A; Portoukalian J; Berthier-Vergnes O
FEBS Lett; 1995 Apr; 362(2):161-4. PubMed ID: 7720864
[TBL] [Abstract][Full Text] [Related]
18. Exogenous GM3 ganglioside inhibits atherosclerosis via multiple steps: A potential atheroprotective drug.
Ao M; Wang K; Zhou X; Chen G; Zhou Y; Wei B; Shao W; Huang J; Liao H; Wang Z; Sun Y; Zeng S; Chen Y
Pharmacol Res; 2019 Oct; 148():104445. PubMed ID: 31526872
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside GM3 is required for caffeic acid phenethyl ester-induced megakaryocytic differentiation of human chronic myelogenous leukemia K562 cells.
Jin UH; Chung TW; Song KH; Kwak CH; Choi HJ; Ha KT; Chang YC; Lee YC; Kim CH
Biochem Cell Biol; 2014 Aug; 92(4):243-9. PubMed ID: 24934090
[TBL] [Abstract][Full Text] [Related]
20. Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3.
Nagafuku M; Sato T; Sato S; Shimizu K; Taira T; Inokuchi J
Glycobiology; 2015 Mar; 25(3):303-18. PubMed ID: 25303960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
